These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 342393)

  • 81. Immunological characteristics of leukemia and lymphoma in allogeneic cell immunity: growth of syngeneic tumors in rats immunized with allogeneic cells.
    Hosokawa M; Yamashita T; Gotohda E; Takeichi N; Kodama T; Kobayashi H
    Int J Cancer; 1978 Jul; 22(1):91-7. PubMed ID: 681026
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Production of anti-self-h-2 antibodies by C3D2F1 mice hyperimmune to L cell/L1210 hybrids and L1210 leukemia cells.
    Kawashima K; Watanabe E; Isobe K; Ogura M; Nagura E; Yamada K; Sobue I; Mizoguchi K; Ito Y; Nagai Y; Nakashima I
    Cell Immunol; 1982 Mar; 67(2):279-86. PubMed ID: 7083334
    [No Abstract]   [Full Text] [Related]  

  • 83. In vivo requirements for the immune recognition of L1210 leukemia cells by allogeneic T-lymphocytes.
    Forni G; Lanfrancone L; Giovarelli M
    Tumori; 1983 Oct; 69(5):403-8. PubMed ID: 6606243
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antibody-forming cells with specificity for syngeneic and allogeneic (thymocyte) tissue antigens following lipopolysaccharide mitogenic stimulation.
    McHugh YH; Bonavida B
    Transplant Proc; 1977 Mar; 9(1):1205-9. PubMed ID: 68566
    [No Abstract]   [Full Text] [Related]  

  • 85. Production of antibodies against ML antigen in the xenogeneic host.
    Radzikowski C; Zak-Nejmark T; Wysocka M; Steuden J
    Arch Immunol Ther Exp (Warsz); 1977; 25(4):507-13. PubMed ID: 931552
    [TBL] [Abstract][Full Text] [Related]  

  • 86. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
    Isakov N; Feldman M; Segal S
    Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Donor cell leukemia after bone marrow transplantation in the Friend leukemia in mice.
    Kreja L; Seidel HJ; Kohne E
    Transplantation; 1980 Feb; 29(2):93-6. PubMed ID: 6986694
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Induction of transplantation resistance to murine L1210 leukemia cells in BCG-primed mice by immunization with tuberculin protein-coupled L1210 cells.
    Ohno R; Kodera Y; Ogura M; Yamada H
    Gan; 1984 Feb; 75(2):187-92. PubMed ID: 6428959
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H; Mihich E
    Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 92. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.
    Schirmbeck R; Böhm W; Reimann J
    J Immunol; 1996 Oct; 157(8):3550-8. PubMed ID: 8871655
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Gross reactivity between synthetic T,GA-L and transplantation antigens in CBA Mice.
    Ebringer A; Davies DA
    Nat New Biol; 1973 Jan; 241(109):144-7. PubMed ID: 4121713
    [No Abstract]   [Full Text] [Related]  

  • 94. Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice.
    Kircheis R; Küpcü Z; Wallner G; Rössler V; Schweighoffer T; Wagner E
    Cancer Gene Ther; 2000 Jun; 7(6):870-8. PubMed ID: 10880017
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo.
    Fioretti MC; Romani L; Bonmassar A; Taramelli D
    J Immunopharmacol; 1980; 2(2):189-212. PubMed ID: 6821551
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Autochthonous grafts of spontaneous mammary tumors implanted together with allogeneic tissues.
    Tokuzen R; Nakahara W
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974; 81(3-4):239-42. PubMed ID: 4154550
    [No Abstract]   [Full Text] [Related]  

  • 97. On tumor Transplantation and Inoculation : (Preliminary Report.).
    Herzog M
    J Med Res; 1902 Jun; 8(1):74-82.3. PubMed ID: 19971497
    [No Abstract]   [Full Text] [Related]  

  • 98. Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes.
    Zarling JM; Kay NE; Grant B; Yasukawa M; Bach FH
    Cancer Immunol Immunother; 1983; 15(3):237-9. PubMed ID: 6604571
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Protection against syngeneic tumor grafts induced by inoculation with normal allogeneic tissues.
    Bear RH; Roholt OA; Pressman D
    Immunol Commun; 1977; 6(6):547-58. PubMed ID: 342393
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Syngeneic tumor rejection induced by immunization with normal allogeneic tissues.
    Bear RH; Roholt OA; Pressman D
    Immunol Commun; 1977; 6(3):217-25. PubMed ID: 885580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.